Canadian Hematology Today

Articles

• 

  Relapsed or Refractory Mantle Cell Lymphoma: Available and Emerging Therapies

  Jean-Nicolas Champagne, MD, FRCPC, Diego Villa, MD, MPH, FRCPC

  5–17

  • PDF (en)
  • PDF (fr)
• 

  Treatment of Philadelphia Chromosome-negative Myeloproliferative Neoplasms in 2024: A Concise Review

  Akhil Rajendra, MD, DM, Dawn Maze, MD, FRCPC, MSc

  19–31

  • PDF (en)
  • PDF (fr)
• 

  Front-line Treatment of Older Patients with Hodgkin Lymphoma

  Kelly Davison, MD

  33–37

  • PDF (en)
  • PDF (fr)
• 

  The Evolving Landscape of DLBCL Treatment Beyond the First Line in 2024

  Mark Bosch, MD

  39–45

  • PDF (en)
  • PDF (fr)
• 

  Minimal Residual Disease in Myeloma in 2024: Where We are Today

  Alfredo De la Torre, MD, Ana-Florencia Ramírez Ibarguen, MD

  47–54

  • PDF (en)
  • PDF (fr)